Continued Pandemic Uncertainty Causes Bank of America to Defer $7.7 Billion in Commercial Loans

In response to a struggling economy amid the coronavirus pandemic, the Bank of America has decided to defer a total of $7.7 billion in loans for its commercial clients.

As of July 23, nearly 2% of the bank’s commercial clients have had their loans modified in some way, such as payment deferrals for durations up to 90 days or waivers on loan covenants. In the meantime, Bank of America’s consumer and small-business division had to defer a total of $28.5 billion in loans, with over of 1.4 million consumers requesting a delay on their credit card payments. Of those that were granted deferrals, approximately 61% have so far made some form of payment, while another 33% have been making timely payments each month.

The Bank of America anticipates the current economic uncertainty to continue for the time being, as coronavirus cases continue to mount and initial job claims fail to show signs of a significant improvement. As a result, the negative macroeconomic environment will most likely contribute to a deterioration of the bank’s businesses.

Information for this briefing was found via Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Why Silver Still Hasn’t Seen the Real Mania | Craig Hemke

Why Copper Needs a Much Higher Price to Fix the Supply Problem | Greg Ferron – PTX Metals

Recommended

Goliath Resources Kicks Off Fully Funded 50,000 Metre Drill Program At Surebet

First Phosphate Lifts Bégin-Lamarche Indicated Tonnage by 378% In Latest Resource Update

Related News

Canadian Federal Government Extends CERB Payments For 8 More Weeks

As mentioned earlier, the Canadian federal government has been pushing a plan to extend CERB...

Wednesday, June 17, 2020, 03:49:00 PM

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three...

Monday, October 26, 2020, 10:54:38 AM

Datametrex Secures Rights To Sell And Distribute Rapid COVID-19 Antigen Test Kits

Datametrex AI (TSXV: DM) this morning announced that it has secured the rights to sell...

Wednesday, August 12, 2020, 09:27:09 AM

Pantry Stockpiling Surges 3,400% As Second COVID-19 Wave Sets In

As the outlook for the coronavirus pandemic turns bleak across the US amid record-breaking surges...

Thursday, October 29, 2020, 10:35:36 AM

Canada’s Cautious Reopening Causes Economic Recovery to Fall Behind Compared to US Counterpart

As coronavirus restrictions are slowly being lifted across the country, the resulting economic damage is...

Friday, June 12, 2020, 05:49:00 PM